(Total Views: 501)
Posted On: 04/15/2020 6:31:26 AM
Post# of 154604
This is what NP said on 2/21 regarding the basket trial:
"Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn, stated, “We currently have more than 70 patients eagerly waiting to participate in this basket trial and expect the first patient injection to take place within approximately ten days. Furthermore, overall enrollment of the trial could be completed in as little as 30 to 60 days, as this is a 30-patient trial.”
Sad CV-19 is affecting the study enrollment. Still, does having injected only one patient by now make sense?
"Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn, stated, “We currently have more than 70 patients eagerly waiting to participate in this basket trial and expect the first patient injection to take place within approximately ten days. Furthermore, overall enrollment of the trial could be completed in as little as 30 to 60 days, as this is a 30-patient trial.”
Sad CV-19 is affecting the study enrollment. Still, does having injected only one patient by now make sense?
(0)
(0)
